Le Point International: Cancer vaccines: why BioNTech is betting on the UK

Published on January 29, 2023

Thomas Roulet, Associate Professor in Organisation Theory and Deputy Director of the MBA programme at Cambridge Judge Business School, is quoted in this article mentioning AstraZeneca’s anti-Covid19 vaccine.

“This vaccine showed this country’s ability to create ecosystems that combine an innovative company, great research universities, the public health system, a teaching hospital, and a state willing to facilitate the process,” says Thomas.

Read the full article [lepoint.fr]

The post Le Point International: Cancer vaccines: why BioNTech is betting on the UK appeared first on Cambridge Judge Business School.

Continue reading on website
Other news

Five tips for the Cambridge MBA application process

January 27, 2023
Emily Brierley, MBA Head of MBA Admissions and Recruitment at Cambridge Judge Business School (CJBS) shares some tips on applying, how to navigate funding, and more. Emily Brierley, MBA Head of MBA Admissions and Recruitment at Cambridge Judge Business School (CJBS) shares some tips on applying, how to navigate funding, and more.Expectations, timings, and deadlinesEmily Brierley“We receive over 1

South China Morning Post: Chinese economist calls for review of rigid cryptocurrency ban as digital yuan fails to take off

January 30, 2023
Research by the Cambridge Centre for Alternative Finance (CCAF) at Cambridge Judge Business School is mentioned in this article regarding the total bitcoin hash rate in China between September 2021 and January 2022.Read the full article [scmp.com]The post South China Morning Post: Chinese economist calls for review of rigid cryptocurrency ban as digital yuan fails to take off appeared first on Cam